Oncternal Therapeutics (NASDAQ:ONCT) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. Other equities analysts have also issued research reports about the stock. Cantor Fitzgerald reiterated a neutral rating and issued a $1.30 target price on shares of Oncternal […]
More Stories
New York State Teachers Retirement System Sells 13,673 Shares of ATI Inc. (NYSE:ATI)
New York State Teachers Retirement System trimmed its position in shares of ATI Inc. (NYSE:ATI – Free Report) by 8.7%...
24 Dead, 20 Girls Missing as Flooding Ravages Central Texas
By Tom Ozimek Catastrophic flash flooding triggered by torrential rainfall has left 24 people dead, others missing, and extensive damage...
Stonebridge Financial Group LLC Has $5.81 Million Stake in Alphabet Inc. (NASDAQ:GOOGL)
Stonebridge Financial Group LLC lifted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 22.3% during the...
California’s Madre Fire Explodes in Size to Cover 70,800 Acres
By Naveen Athrappully A wildfire in California’s San Luis Obispo County has greatly expanded to now cover almost 70,800 acres...
Skylands Capital LLC Has $28.75 Million Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Skylands Capital LLC boosted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 19.6% during the 1st...
Avidian Wealth Enterprises LLC Sells 712 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Avidian Wealth Enterprises LLC reduced its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.4% in the...